A detailed history of Walleye Capital LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Walleye Capital LLC holds 76,800 shares of LEGN stock, worth $3.07 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
76,800
Previous 4,000 1820.0%
Holding current value
$3.07 Million
Previous $224,000 1418.3%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$39.5 - $57.22 $5.24 Million - $7.6 Million
132,762 Added 5991.06%
134,978 $5.98 Million
Q1 2024

May 15, 2024

BUY
$55.06 - $69.99 $122,012 - $155,097
2,216 New
2,216 $124,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.7B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.